Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • moses2111 moses2111 Jul 2, 2011 2:00 PM Flag

    Updated stats

    Updated stats are as follows


    11/17/04 -$100,000 ($27.99) Inception of $100,000 investment
    12/16/04 - $109,000 ($28.98) Last close this high
    12/17/04 - $078,000 ($25.75 ) Adverse Celebrex test
    06/23/05 - $134,000 ($28.90) 2005 closing high
    12/09/05 - $031,605 ($20.60) 2005 closing low
    12/31/05 - $067,335 ($23.32) Year-end 2005 close
    07/17/06 - $044,500 ($22.41) 2006 closing low
    09/20/06 - $182,000 ($28.47) 2006 closing high
    12/04/06 - $098,985 ($24.90) Torcetrapib failure
    12/29/06 - $128,925 ($25.90) Year-end 2006 close
    01/19/07 - $181,000 ($27.22) Interim recovery high
    06/01/07 - $196,065 ($27.68) 2007 closing high
    08/16/07 - $069,210 ($23.39) Interim bottom for subprime slime
    10/05/07 - $138,925 ($25.58) Top of the market
    11/26/07 - $027,895 ($22.30) Closing low for 2007
    12/31/07 - $037,845 ($22.73) Year-end 2007 close
    01/10/08 - $079,945 ($24.08) 2008 closing high
    06/02/08 - ($78,995) $19.18) Shocking WSJ article AH
    08/15/08 - ($49,945) ($19.97) Interim high
    10/10/08 - (142,345) ($15.14) 10-session S & P crash of 25.9%
    11/04/08 - ($65,755) ($18.14) 6-session S & P surge of 18.5%
    11/20/08 - (154,230) ($14.45) Lowest close since Apr. 1997
    12/31/08 - ($53,340) ($17.71) Year-end 2008 close
    01/23/09 - ($60,750) ($17.45) WYE talks disclosed
    01/30/09 - (148,350) ($14.58) 16.4% plunge in a week following dividend cut
    03/02/09 - (232,995) ($11.66) Lowest close since 8/1/96
    03/06/09 - (200,050) ($12.73) $1M Mulligan begins at close
    07/27/09 - ($49,555) ($16.62) PFE up 17.0% in 11 sessions. RSI 74.6
    10/14/09 - ($02,730) ($17.37) Final regulatory approval for WYE deal
    12/01/09 - 043,090 - ($18.85) Closing high for 2009
    12/08/09 - 020,220 - ($17.76) Last reaction low close - RSI 46.7
    12/31/09 - 043,175 - ($18.19) Year-end 2009 close
    01/19/10 - 093,230 - ($20.00) 2010 Closing high. RSI 73.7
    01/20/10 - 094,670 - ($19.94) 2010 valuation high. Visine Minute seen
    01/29/10 - 063,310 - ($18.66) Dow loses 658 points in 8 sessions
    02/02/10 - 086,145 - ($19.24) Session prior to earnings and dividend
    02/03/10 - 068,115 - ($18.62) Earnings disappoint analysts, 18-cent ex-dividend
    03/02/10 - 034,930 - ($17.60) Session prior to Dimebon failure
    05/20/10 ($80,835) - ($15.23) RSI 28.7, low closing reading of year
    06/24/10 (129,265) - ($14.46) Tanezumab failure
    07/02/10 (147,420) - ($14.14) 2010 Closing low. RSI 31.1
    08/04/10 ($24,915) - ($16.44) Ex-dividend 18 cents, RSI 72.6
    09/15/10 - 023,275 - ($17.27) RSI 71.5, outperformance peak vs. S & P
    10/18/10 - 048,020 - ($17.80) RSI 65.7
    11/30/10 -($12,725)- ($16.30) RSI 36.4
    12/03/10 - 015,740 - ($16.72) Kindler's last day
    12/09/10 - 018,965 - ($16.76) Underperformance low vs S & P
    12/31/10 - 066,105 - ($17.51) Year-end 2010 close

    01/03 - 071,465 - ($17.68) 2011 Closing low
    01/07 - 096,500 - ($18.34) RSI 76.0, highest in 53 months
    01/21 - 102,880 - ($18.36) Annual LEAPS options expire
    01/28 - 096,085 - ($18.15) RSI 53.8
    02/01 - 130,580 - ($19.22) 2012 earnings reaffirmed; new $5B buyback plan
    02/02 - 121,925 - ($18.96) Ex-dividend 20 cents
    02/04 - 131,540 - ($19.30) RSI 75.3, decade-long downtrend line shattered
    02/11 - 120,055 - ($18.83) RSI 59.3
    02/17 - 137,860 - ($19.37) RSI 68.4
    02/23 - 116,160 - ($18.76) RSI 51.6
    03/03 - 151,580 - ($19.77) RSI 68.3
    03/16 - 135,900 - ($19.30) RSI 51.6
    04/11 - 183,710 - ($20.67) RSI 66.1
    04/21 - 154,810 - ($19.79) RSI 40.6, Tofacitinib test scare
    05/02 - 202,790 - ($21.02) RSI 64.6
    05/05 - 184,845 - ($20.39) RSI 50.1, Commodities tumble
    05/11 - 190,915 - ($20.61) Ex-dividend 20 cents
    05/31 - 221,375 - ($21.45) RSI 66.4, all-time high valuation
    06/10 - 176,540 - ($20.11) RSI 38.1, 2011 Closing low RSI
    06/23 - 201,340 - ($20.65) RSI 52.3 Super Eliquis test results
    06.24 - 176,355 - ($20.08) RSI 42.2, Remoxy approval delayed
    07/01 - 212,280 - ($20.75) RSI 54.5, Greeks accept austerity

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PFE
35.27-0.09(-0.25%)Apr 24 4:00 PMEDT